| Basics |
CareDx, Inc.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
|
| IPO Date: |
July 17, 2014 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$953.05M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.62 | 3.07%
|
| Avg Daily Range (30 D): |
$0.46 | 2.82%
|
| Avg Daily Range (90 D): |
$0.34 | 2.33%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
.88M |
| Avg Daily Volume (90 D): |
1.05M |
| Trade Size |
| Avg Trade Size (Sh.): |
77 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
72 |
| Institutional Trades |
| Total Inst.Trades: |
3,368 |
| Avg Inst. Trade: |
$2.35M |
| Avg Inst. Trade (30 D): |
$1.83M |
| Avg Inst. Trade (90 D): |
$1.87M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.84M |
| Avg Closing Trade (30 D): |
$1.97M |
| Avg Closing Trade (90 D): |
$2.2M |
| Avg Closing Volume: |
117.84K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.03
|
$-.16
|
|
Diluted EPS
|
|
$.03
|
$-.16
|
|
Revenue
|
$
|
$ 100.06M
|
$ 86.68M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ 1.68M
|
$ -8.57M
|
|
Operating Income / Loss
|
$
|
$ -.25M
|
$ -11.12M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ 23.23M
|
$ -20.52M
|
|
PE Ratio
|
|
|
|
|
|
|
